Related Experiment Video
Updated: May 30, 2026

Using the Open-Source MALDI TOF-MS IDBac Pipeline for Analysis of Microbial Protein and Specialized Metabolite Data
Published on: May 15, 2019
[Biobadaser 2.0: analysis and trends in 2009]
Miguel Ángel Descalzo1, Loreto Carmona,
1Unidad de Investigación, Sociedad Española de Reumatología, Madrid, España.
Long-term safety data from the BIOBADASER 2.0 registry show that biological therapies for rheumatic diseases have a similar risk profile to previous years. Most adverse events were non-serious, with infections being the most common.
Area of Science:
- Rheumatology
- Pharmacovigilance
- Clinical Epidemiology
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Related Concept Videos
Genomics
Biostatistics: Overview
Discrete variables are...
Statistical Methods for Analyzing Epidemiological Data
Statistical Analysis: Overview
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...